Evidence map›Paper›PMID 26450360›Full record

ArticleEuropean journal of clinical pharmacology2016

Identification of Dutch children diagnosed with atopic diseases using prescription data: a validation study.

B Mulder, F Groenhof, L I Kocabas, H J Bos, T W De Vries, E Hak, Ccm Schuiling-Veninga

Open access · hybridAbstract readValidation Study
In one paragraph

Article in European journal of clinical pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

B MulderDepartment of PharmacoEpidemiology and PharmacoEconomics University Centre of Pharmacy, University of Groningen, P.O. Box XB45, A. Deusinglaan 1, 9713 AV, Groningen, The Netherlands. b.mulder@rug.nl.
F GroenhofDepartment of General Practice, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
L I KocabasDepartment of PharmacoEpidemiology and PharmacoEconomics University Centre of Pharmacy, University of Groningen, P.O. Box XB45, A. Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
H J BosDepartment of PharmacoEpidemiology and PharmacoEconomics University Centre of Pharmacy, University of Groningen, P.O. Box XB45, A. Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
T W De VriesDepartment of Pediatrics, Medical Centre Leeuwarden, H Dunantweg 2, 8934 AD, Leeuwarden, The Netherlands.
E HakDepartment of PharmacoEpidemiology and PharmacoEconomics University Centre of Pharmacy, University of Groningen, P.O. Box XB45, A. Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
Ccm Schuiling-VeningaDepartment of PharmacoEpidemiology and PharmacoEconomics University Centre of Pharmacy, University of Groningen, P.O. Box XB45, A. Deusinglaan 1, 9713 AV, Groningen, The Netherlands.
University of Groningen · NLUniversity Medical Center Groningen · NLMedisch Centrum Leeuwarden · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe aim of this study is to validate medication proxies for the identification of children diagnosed with atopic disorders that can be applied in various types of epidemiological research.

methodsRecords of 7439 children, aged between 0 and 10 years, in the period 2001 until 2010, were retrieved from the Registration Network Groningen database, a general practitioners database in the north-eastern part of the Netherlands. The sensitivity and positive predictive value (PPV) of 22 medication proxies for the identification of children diagnosed with atopic disorders (asthma, atopic dermatitis, and allergic rhinitis) were computed using the registered diagnoses as gold standards. In addition, different capture periods (1 year, half year, and length of study period) for the detection of prescriptions were tested for all the medication proxies.

resultsThe highest PPV (0.84, 95 % CI 0.81-0.87) in combination with a sufficient sensitivity value (0.54, 95 % CI 0.50-0.57) for the identification of children diagnosed with asthma was yielded for the medication proxy, ≥2 prescriptions for anti-asthma medication within 1 year, including 1 inhaled steroid. PPV and sensitivity were even higher in the age group 6-10 years. The proxies designed for the identification of children diagnosed with atopic dermatitis and allergic rhinitis yielded only high PPVs (≥0.75) in combination with low sensitivity values (≤0.22). Altering the capture period for the detection of prescriptions to half a year or the length of the study period only affected sensitivity values.

conclusionChildren diagnosed with asthma can be identified reliably with a range of medication proxies. The use of prescription data for the identification of children diagnosed with atopic dermatitis and allergic rhinitis is questionable.

Indexed as

Adrenal Cortex HormonesAnti-Asthmatic AgentsAsthmaChildChild, PreschoolCross-Sectional StudiesDatabases, FactualDermatitis, AtopicDrug PrescriptionsDrug UtilizationGeneral PractitionersHistamine AntagonistsHumansImmunosuppressive AgentsInfantInfant, NewbornAdrenal Cortex HormonesAnti-Asthmatic AgentsHistamine AntagonistsImmunosuppressive AgentsAsthmaAtopic diseasesEczemaHay feverPrescriptionsSensitivitySpecificity

Identifiers

PMID26450360
PMCPMC4701779
OpenAlexW2328114731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.